Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124751683 | 12475168 | 3 | F | 201605 | 20160808 | 20160617 | 20160817 | PER | US-PFIZER INC-2016267834 | PFIZER | 66.00 | YR | M | Y | 134.00000 | KG | 20160817 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124751683 | 12475168 | 1 | PS | SIROLIMUS. | SIROLIMUS | 1 | Oral | 1 MG, DAILY PILL BY MOUTH | N0230 | 21110 | 1 | MG | TABLET | ||||||
| 124751683 | 12475168 | 2 | SS | SIROLIMUS. | SIROLIMUS | 1 | Oral | 1 MG, ALTERNATE DAY PILL BY MOUTH | 21110 | 1 | MG | TABLET | QOD | ||||||
| 124751683 | 12475168 | 3 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20 MG, DAILY BY MOUTH | 0 | 20 | MG | ||||||||
| 124751683 | 12475168 | 4 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 150 UG, DAILY; 150MCG ONCE DAILY PILL BY MOUTH | 0 | 150 | UG | ||||||||
| 124751683 | 12475168 | 5 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | Oral | 400 IU, 2X/DAY BY MOUTH | 0 | 400 | IU | CAPSULE | BID | ||||||
| 124751683 | 12475168 | 6 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 325 MG, 1X/DAY BY MOUTH | 0 | 325 | MG | TABLET | QD | ||||||
| 124751683 | 12475168 | 7 | C | TERAZOSIN | TERAZOSINTERAZOSIN HYDROCHLORIDE | 1 | Oral | 1 MG, 1X/DAY BY MOUTH | 0 | 1 | MG | CAPSULE | QD | ||||||
| 124751683 | 12475168 | 8 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 40 MG, 1X/DAY BY MOUTH | 0 | 40 | MG | QD | |||||||
| 124751683 | 12475168 | 9 | C | ATORVASTATIN | ATORVASTATIN | 1 | UNK | 0 | |||||||||||
| 124751683 | 12475168 | 10 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 50 MG, 2X/DAY; 50MG PILL ONE IN MORNING AND ONE IN AFTERNOON BY MOUTH | 0 | 50 | MG | BID | |||||||
| 124751683 | 12475168 | 11 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 100 MG, 2X/DAY; ONE IN THE MORNING AND ONE IN THE EVENING BY MOUTH | 0 | 100 | MG | TABLET | BID | ||||||
| 124751683 | 12475168 | 12 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | Oral | 4 MG, 2X/DAY; 4MG TABLET ONE IN THE MORNING AND ONE IN THE EVENING BY MOUTH | 0 | 4 | MG | TABLET | BID | ||||||
| 124751683 | 12475168 | 13 | C | NOVOLIN R | INSULIN HUMAN | 1 | 3X/DAY; 55 UNITS IN THE MORNING, 55 UNITS IN AFTERNOON AND 60 UNITS AT NIGHT INJECTION | 0 | INJECTION | TID | |||||||||
| 124751683 | 12475168 | 14 | C | LANTUS | INSULIN GLARGINE | 1 | 2X/DAY; 60 UNITS IN MORNING AND 60UNITS AT NIGHT INJECTION | 0 | 60 | IU | INJECTION | BID | |||||||
| 124751683 | 12475168 | 15 | C | CALCIUM D | CALCIUMVITAMIN D | 1 | Oral | 1 DF, 2X/DAY; ONE PILL IN THE MORNING AND ONE PILL IN AFTERNOON BY MOUTH | 0 | 1 | DF | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124751683 | 12475168 | 1 | Liver transplant rejection |
| 124751683 | 12475168 | 3 | Fluid retention |
| 124751683 | 12475168 | 5 | Cardiac disorder |
| 124751683 | 12475168 | 6 | Blood disorder |
| 124751683 | 12475168 | 8 | Blood cholesterol |
| 124751683 | 12475168 | 10 | Hypertension |
| 124751683 | 12475168 | 11 | Gout |
| 124751683 | 12475168 | 12 | Blood glucose increased |
| 124751683 | 12475168 | 13 | Blood glucose increased |
| 124751683 | 12475168 | 14 | Blood glucose increased |
| 124751683 | 12475168 | 15 | Bone disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124751683 | 12475168 | Intentional product misuse | |
| 124751683 | 12475168 | Pollakiuria | |
| 124751683 | 12475168 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124751683 | 12475168 | 1 | 2016 | 0 | ||
| 124751683 | 12475168 | 3 | 2014 | 0 | ||
| 124751683 | 12475168 | 4 | 2006 | 0 | ||
| 124751683 | 12475168 | 5 | 2010 | 0 | ||
| 124751683 | 12475168 | 6 | 2010 | 0 | ||
| 124751683 | 12475168 | 7 | 2009 | 0 | ||
| 124751683 | 12475168 | 8 | 2014 | 0 | ||
| 124751683 | 12475168 | 9 | 2015 | 0 | ||
| 124751683 | 12475168 | 10 | 2005 | 0 | ||
| 124751683 | 12475168 | 11 | 2008 | 0 | ||
| 124751683 | 12475168 | 12 | 2013 | 0 | ||
| 124751683 | 12475168 | 13 | 2013 | 0 | ||
| 124751683 | 12475168 | 14 | 2005 | 0 | ||
| 124751683 | 12475168 | 15 | 2001 | 0 |